HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More…
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Phone801-727-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$287.24 million
Profitability
Miscellaneous
Employees1,141
Next Earnings Date12/3/2019 (Estimated)
OptionableOptionable
Healthequity (NASDAQ:HQY) Frequently Asked Questions
What is Healthequity's stock symbol?
Healthequity trades on the NASDAQ under the ticker symbol "HQY."
How were Healthequity's earnings last quarter?
Healthequity Inc (NASDAQ:HQY) issued its quarterly earnings data on Tuesday, September, 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.26 by $0.10. The company earned $86.60 million during the quarter, compared to the consensus estimate of $85.33 million. Healthequity had a net margin of 28.13% and a return on equity of 11.77%. The firm's revenue was up 21.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.36 earnings per share. View Healthequity's Earnings History.
When is Healthequity's next earnings date?
What guidance has Healthequity issued on next quarter's earnings?
Healthequity issued an update on its FY 2020 earnings guidance on Tuesday, September, 3rd. The company provided EPS guidance of $1.10-1.16 for the period, compared to the Thomson Reuters consensus estimate of $1.33. The company issued revenue guidance of $341-347 million, compared to the consensus revenue estimate of $343.28 million.
What price target have analysts set for HQY?
12 Wall Street analysts have issued twelve-month price targets for Healthequity's stock. Their forecasts range from $56.00 to $102.00. On average, they anticipate Healthequity's share price to reach $78.15 in the next year. This suggests a possible upside of 46.4% from the stock's current price. View Analyst Price Targets for Healthequity.
What is the consensus analysts' recommendation for Healthequity?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 1 hold rating, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.
What are Wall Street analysts saying about Healthequity stock?
Here are some recent quotes from research analysts about Healthequity stock:
- 1. According to Zacks Investment Research, "Strong growth in Service and Custodial revenue segments buoy optimism HealthEquity. Notably, solid growth in HSAs and custodial assets provided a boost to the company’s top-line performance. Currently, HealthEquity is the second-largest HSA custodian in terms of market share. These apart, HealthEquity’s 401(K) solution, which lowers the cost, risk and work of managing a retirement plan, bodes well for the company. Moreover, management is optimistic about the launch of HealthEquity retirement services. Reflective of the trends exhibited by the company, the stock outperformed its industry year to date. On the flip side, HealthEquity faces stiff competition in Medical Services markets. HealthEquity is required to comply with strict Treasury Regulations formulated by the Internal Revenue Service or the IRS." (5/21/2019)
- 2. Cantor Fitzgerald analysts commented, ". We are upgrading the shares of from Neutral. Our price target remains $82, or roughly 38% above current levels. HQY shares have struggled since the company reported F3Q19 results earlier this month. We believe fundamentals remain strong as HQY continues to benefit from continued adoption of health savings accounts (HSA). The company continues to grow above market rates. In the most recent quarter, HQY’s HSA members grew by 22%, which compares with Webster Bank, which reported account growth of just 12%. Earnings continue to benefit from a higher interest environment, even with a slight moderation in 10-year interest rates lately." (12/17/2018)
Has Healthequity been receiving favorable news coverage?
News coverage about HQY stock has been trending negative this week, InfoTrie reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Healthequity earned a news impact score of -2.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Healthequity.
Are investors shorting Healthequity?
Healthequity saw a decrease in short interest in September. As of September 30th, there was short interest totalling 5,860,000 shares, a decrease of 7.4% from the August 30th total of 6,330,000 shares. Based on an average daily trading volume, of 1,100,000 shares, the days-to-cover ratio is currently 5.3 days. Currently, 8.5% of the company's stock are short sold. View Healthequity's Current Options Chain.
Who are some of Healthequity's key competitors?
Some companies that are related to Healthequity include Akamai Technologies (AKAM), Broadridge Financial Solutions (BR), LYFT (LYFT), The Western Union (WU), Fair Isaac (FICO), WEX (WEX), Nielsen (NLSN), Etsy (ETSY), Zillow Group (Z), Zillow Group (ZG), Alliance Data Systems (ADS), CDK Global (CDK), GrubHub (GRUB), CIELO S A/S (CIOXY) and MAXIMUS (MMS).
What other stocks do shareholders of Healthequity own?
Who are Healthequity's key executives?
Healthequity's management team includes the folowing people:
- Mr. Jon Kessler, Pres, CEO & Director (Age 51)
- Stephen D. Neeleman, Founder & Vice Chairman (Age 51)
- Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)
- Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)
- Mr. William Robert Otten, Exec. VP of Sales (Age 54)
Who are Healthequity's major shareholders?
Healthequity's stock is owned by a number of of institutional and retail investors. Top institutional investors include Copper Rock Capital Partners LLC (0.39%), Scout Investments Inc. (0.17%), Pacer Advisors Inc. (0.04%), Gradient Investments LLC (0.03%), State of Alaska Department of Revenue (0.02%) and Radnor Capital Management LLC (0.01%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.
Which institutional investors are selling Healthequity stock?
HQY stock was sold by a variety of institutional investors in the last quarter, including Altfest L J & Co. Inc.. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Darcy G Mott, Delano Ladd and Frank Corvino. View Insider Buying and Selling for Healthequity.
Which institutional investors are buying Healthequity stock?
HQY stock was bought by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, State of Alaska Department of Revenue, Radnor Capital Management LLC, Scout Investments Inc., Pacer Advisors Inc., Cerebellum GP LLC and Gradient Investments LLC. View Insider Buying and Selling for Healthequity.
How do I buy shares of Healthequity?
Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Healthequity's stock price today?
One share of HQY stock can currently be purchased for approximately $53.40.
How big of a company is Healthequity?
Healthequity has a market capitalization of $3.77 billion and generates $287.24 million in revenue each year. The company earns $73.90 million in net income (profit) each year or $0.95 on an earnings per share basis. Healthequity employs 1,141 workers across the globe.View Additional Information About Healthequity.
What is Healthequity's official website?
How can I contact Healthequity?
Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]
MarketBeat Community Rating for Healthequity (NASDAQ HQY)
MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days.
